Literature DB >> 25015454

Paclitaxel-resistant HeLa cells have up-regulated levels of reactive oxygen species and increased expression of taxol resistance gene 1.

Wenxiang Bi1, Yuxia Wang2, Gaoying Sun1, Xiaojin Zhang1, Yongqing Wei2, Lu Li2, Xiaoyuan Wang3.   

Abstract

This study is to establish a paclitaxel (PTX)-resistant human cervical carcinoma HeLa cell line (HeLa/PTX) and to investigate its redox characteristics and the expression of taxol resistance gene 1 (Txr1). HeLa cells were treated with PTX and effects of PTX on cell proliferation were detected through cell counting and the MTT assay. Levels of cellular reactive oxygen species (ROS), reduced glutathione (GSH), and oxidized glutathione (GSSG) as well as the ratio of GSH to GSSG were measured by the 2,7-difluorescein diacetate (DCFH-DA) method and the 5,5'dithiobis(2-nitrobenzoic acid) (DTNB) method. Activities of superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx) were determined by the nitrite formation method, the molybdate colorimetric method, and the DTNB colorimetric method, respectively. The level of Txr1 mRNA was determined by real-time PCR. Compared with the regular HeLa cells, HeLa/PTX cells were larger in size and had more cytoplasmic granules. The population doubling time for HeLa/PTX cells was 1.32 times of that of HeLa cells (P<0.01). HeLa/PTX cells showed stronger resistance to PTX than HeLa cells with a resistance index of 122.69. HeLa/PTX cells had higher levels of ROS (P<0.01) and Txr1 mRNA (P<0.01), lower level of GSH (P < 0.05), and lower activities of SOD (P<0.01) and GPx (P < 0.05) than HeLa cells. HeLa/PTX cells, with higher levels of ROS and Txr1 mRNA expression, are more resistant to PTX than HeLa cells.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25015454

Source DB:  PubMed          Journal:  Pak J Pharm Sci        ISSN: 1011-601X            Impact factor:   0.684


  5 in total

1.  A protocol of homozygous haploid callus induction from endosperm of Taxus chinensis Rehd. var. mairei.

Authors:  Yan-Lin Li; San-Wen Huang; Jia-Yin Zhang; Feng-Jiao Bu; Tao Lin; Zhong-Hua Zhang; Xing-Yao Xiong
Journal:  Springerplus       Date:  2016-06-01

2.  Curcumin-carrying nanoparticles prevent ischemia-reperfusion injury in human renal cells.

Authors:  Yong Xu; Ning Hu; Wei Jiang; Hong-Fang Yuan; Dong-Hui Zheng
Journal:  Oncotarget       Date:  2016-12-27

3.  Shikonin induces mitochondria-mediated apoptosis and attenuates epithelial-mesenchymal transition in cisplatin-resistant human ovarian cancer cells.

Authors:  Kristina Shilnikova; Mei Jing Piao; Kyoung Ah Kang; Yea Seong Ryu; Jeong Eon Park; Yu Jae Hyun; Ao Xuan Zhen; Yong Joo Jeong; Uhee Jung; In Gyu Kim; Jin Won Hyun
Journal:  Oncol Lett       Date:  2018-02-15       Impact factor: 2.967

4.  Effects of taxol resistance gene 1 on the cisplatin response in gastric cancer.

Authors:  Shuquan Duan; Jie Yin; Zhigang Bai; Zhongtao Zhang
Journal:  Oncol Lett       Date:  2018-03-30       Impact factor: 2.967

5.  Overexpression of PRR11 promotes tumorigenic capability and is associated with progression in esophageal squamous cell carcinoma.

Authors:  Li Zhou; Zhe-Zhi Deng; Hai-Yan Li; Nan Jiang; Zhi-Sheng Wei; Ming-Fan Hong; Ji-Hui Wang; Ming-Xing Zhang; Yi-Hua Shi; Zheng-Qi Lu; Xu-Ming Huang
Journal:  Onco Targets Ther       Date:  2019-04-09       Impact factor: 4.147

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.